An individual patient data metaanalysis of outcomes and prognostic factors after treatment of oligometastatic non-small-cell lung cancer

Clinical Lung Cancer

Volumn 15, Issue 5, 2014, Pages 346-355

  Ashworth, Allison B ^a   Senan, Suresh ^b   Palma, David A ^a   Riquet, Marc ^c   Ahn, Yong Chan ^d   Ricardi, Umberto ^e   Congedo, Maria T ^f   Gomez, Daniel R ^g   Wright, Gavin M ^h   Melloni, Giulio ⁱ   Milano, Michael T ^j   Sole, Claudio V ^k   De Pas, Tommaso M ^l   Carter, Dennis L ^m   Warner, Andrew J ^a   Rodrigues, George B ^a  

^a LONDON REGIONAL CANCER PROGRAM   (Canada)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

^d Sungkyunkwan University School of Medicine   (South Korea)

^e UNIVERSITY OF TURIN   (Italy)

^f CATHOLIC UNIVERSITY   (Italy)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^h UNIVERSITY OF MELBOURNE   (Australia)

ⁱ SAN RAFFAELE HOSPITAL   (Italy)

^j UNIVERSITY OF ROCHESTER   (United States)

^k Instituto Madrileno de Oncologia   (Spain)

^l EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

^m ROCKY MOUNTAIN CANCER CENTERS   (United States)

more..

Author keywords

Metastectomy; NSCLC; Oligometastases; Radiotherapy; SABR SBRT

Indexed keywords

ABLATION THERAPY; ARTICLE; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER SURVIVAL; CLINICAL DECISION MAKING; EXTERNAL BEAM RADIOTHERAPY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; INTERMEDIATE RISK POPULATION; LONG TERM SURVIVAL; LOW RISK POPULATION; LUNG ADENOCARCINOMA; LUNG METASTASIS; META ANALYSIS; METASTASIS RESECTION; MULTIMODALITY CANCER THERAPY; NON SMALL CELL LUNG CANCER; OVERALL SURVIVAL; PATIENT CODING; PREDICTIVE VALUE; PRIMARY TUMOR; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT; STEREOTACTIC BODY RADIATION THERAPY; STEREOTACTIC RADIOSURGERY; SYSTEMATIC REVIEW; TREATMENT OUTCOME; TUMOR ABLATION; TUMOR DIFFERENTIATION; ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE FREE SURVIVAL; LUNG NEOPLASMS; METASTASIS; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RISK; SURVIVAL RATE;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; DISEASE-FREE SURVIVAL; HUMANS; LUNG NEOPLASMS; NEOPLASM METASTASIS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RISK; SURVIVAL RATE;

EID: 84908249715     PISSN: 15257304     EISSN: 19380690     Source Type: Journal    
DOI: 10.1016/j.cllc.2014.04.003     Document Type: Article

References (56)

1. A. Jemal, F. Bray, and M.M. Center Global cancer statistics CA Cancer J Clin 61 2011 69 90
2. W. Curran, R. Paulus, and C. Langer Sequential vs concurrent chemoradiation for stage III non-small-cell lung cancer: randomized phase III trial RTOG 9410 J Natl Cancer Inst 103 2011 1452 1460
3. K. Albain, R. Swann, and V. Rusch Radiotherapy plus chemotherapy with or without surgical resection for stage III non-small-cell lung cancer: a phase III randomised controlled trial Lancet 374 2009 379 386
4. F. Grossi, K. Kubota, and F. Cappuzzo Future scenarios for the treatment of advanced non-small-cell lung cancer: focus on taxane-containing regimens Oncologist 15 2010 1102 1112
5. D.S. Ettinger, W. Akerley, and H. Borghaei Non-small cell lung cancer, version 2.2013 J Natl Compr Canc Netw 11 2013 645 653 quiz 653
6. D.E. Gerber, and J.H. Schiller Maintenance chemotherapy for advanced non-small-cell lung cancer: new life for an old idea J Clin Oncol 31 2013 1009 1020
7. M. Maemondo, A. Inoue, and K. Kobayashi Gefitinib or chemotherapy for non-small-cell lung cancer with mutated EGFR N Engl J Med 362 2010 2380 2388
8. S. Hellman, and R.R. Weichselbaum Oligometastases J Clin Oncol 13 1995 8 10
9. R.R. Weichselbaum, and S. Hellman Oligometastases revisited Nat Rev Clin Oncol 8 2011 378 382
10. N. Mehta, A.M. Mauer, and S. Hellman Analysis of further disease progression in metastatic non-small-cell lung cancer: implications for locoregional treatment Int J Oncol 25 2004 1677 1683
11. K.E. Rusthoven, S.F. Hammerman, and B.D. Kavanagh Is there a role for consolidative stereotactic body radiation therapy following first-line systemic therapy for metastatic lung cancer? A patterns-of-failure analysis Acta Oncol 48 2009 578 583
12. C. Villarreal-Garza, D. de la Mata, and D.G. Zavala Aggressive treatment of primary tumor in patients with non-small-cell lung cancer and exclusively brain metastases Clin Lung Cancer 14 2013 6 13
13. J. Pfannschmidt, and H. Dienemann Surgical treatment of oligometastatic non-small-cell lung cancer Lung Cancer 69 2010 251 258
14. M.T. Milano, A.W. Katz, and H. Zhang Oligometastases treated with stereotactic body radiotherapy: long-term follow-up of prospective study Int J Radiat Oncol Biol Phys 83 2012 878 886
15. D. De Ruysscher, R. Wanders, and A. van Baardwijk Radical treatment of non-small-cell lung cancer patients with synchronous oligometastases: long-term results of a prospective phase II trial (NCT01282450) J Thorac Oncol 7 2012 1547 1555
16. M.D. Hasselle, D.J. Haraf, and K.E. Rusthoven Hypofractionated image-guided radiation therapy for patients with limited volume metastatic non-small-cell lung cancer J Thorac Oncol 7 2012 376 381
17. A. Ashworth, G. Rodrigues, and G. Boldt Is there an oligometastatic state in NSCLC? A systematic review of the literature Lung Cancer 82 2013 197 203
18. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I non-small-cell lung carcinoma: clinical outcomes in 245 subjects in a Japanese multi-institutional study Cancer 101 2004 1623 1631
19. D. Palma, C.J. Haasbeek, and G. Rodrigues Stereotactic ablative radiotherapy for comprehensive treatment of oligometastatic tumors (SABR-COMET): study protocol for a randomized phase II trial BMC Cancer 12 2012 305
20. M. Daniels, and G.M. Wright Complete resection of non-small-cell lung cancer and oligo-metastatic brain disease Aust N Z J Surg 75 2005 963 966
21. T.M. De Pas, F. de Braud, and G. Catalano Oligometastatic non-small-cell lung cancer: a multidisciplinary approach in the positron emission tomographic scan era Ann Thorac Surg 83 2007 231 234
22. H. Kim, Y.C. Ahn, and H.C. Park Results and prognostic factors of hypofractionated stereotactic radiation therapy for primary or metastatic lung cancer J Thorac Oncol 5 2010 526 532
23. C. Lo, C. Yu, and C. Ma Surgical management of primary non-small-cell carcinoma of lung with synchronous solitary brain metastasis: local experience Hong Kong Med J 16 2010 186 191
24. J.L. Lopez Guerra, D. Gomez, and Y. Zhuang Prognostic impact of radiation therapy to the primary tumor in patients with non-small-cell lung cancer and oligometastasis at diagnosis Int J Radiat Oncol Biol Phys 84 2012 e61 e67
25. M. Lucchi, P. Dini, and M.C. Ambrogi Metachronous adrenal masses in resected non-small-cell lung cancer patients: therapeutic implications of laparoscopic adrenalectomy Eur J Cardiothorac Surg 27 2005 753 756
26. G. Melloni, A. Bandiera, and V. Gregorc Combined treatment of non-small-cell lung cancer with synchronous brain metastases: a single center experience J Cardiovasc Surg 52 2011 613 619
27. O. Mercier, E. Fadel, and M. de Perrot Surgical treatment of solitary adrenal metastasis from non-small-cell lung cancer J Thorac Cardiovasc Surg 130 2005 136 140
28. P. Mordant, A. Arame, and F. De Dominicis Which metastasis management allows long-term survival of synchronous solitary M1b non-small-cell lung cancer? Eur J Cardiothorac Surg 41 2012 617 622
29. E.A. Popovic, G.C. Fabinyi, and G.A. Brazenor Craniotomy and thoracotomy for non-small-cell carcinoma of the lung with cerebral metastasis Aust N Z J Surg 63 1993 341 345
30. H. Porte, J. Siat, and B. Guibert Resection of adrenal metastases from non-small-cell lung cancer: a multicenter study Ann Thorac Surg 71 2001 981 985
31. U. Ricardi, A.R. Filippi, and A. Guarneri Stereotactic body radiation therapy for lung metastases Lung Cancer 75 2012 77 81
32. S. Salah, T. Tanvetyanon, and S. Abbasi Metastatectomy for extra-cranial extra-adrenal non-small-cell lung cancer solitary metastases: systematic review and analysis of reported cases Lung Cancer 75 2012 9 14
33. M. Scorsetti, F. Alongi, and A.R. Filippi Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients Acta Oncologica 51 2012 618 623
34. R. Lei, S. Fryman, and A. White A prospective investigation of definitive targeted therapy for solid malignancies with oligometastases Int J Radiat Oncol Biol Phys 84 2012 6
35. G.H. Griffioen, D. Toguri, and M. Dahele Radical treatment of synchronous oligometastatic non-small-cell lung carcinoma (NSCLC): patient outcomes and prognostic factors Lung Cancer 82 2013 95 102
36. Howlader N, Noone AM, Krapcho M, et al. SEER Cancer Statistics Review, 1975-2010. National Cancer Institute, Bethesda, MD, 2012, posted to the SEER web site, 2013, based on November 2012 SEER data submission, Available at: http://seer.cancer.gov/csr/1975-2011/. Accessed: October 15, 2013.
37. R. Rami-Porta, J.J. Crowley, and P. Goldstraw The revised TNM staging system for lung cancer Ann Thorac Cardiovasc Surg 15 2009 4 9
38. P.S. Billing, D.L. Miller, and M.S. Allen Surgical treatment of primary lung cancer with synchronous brain metastases J Thorac Cardiovasc Surg 122 2001 548 553
39. A. Iwasaki, T. Shirakusa, and Y. Yoshinaga Evaluation of the treatment of non-small-cell lung cancer with brain metastasis and the role of risk score as a survival predictor Eur J Cardiothorac Surg 26 2004 488 493
40. D.J. Raz, M. Lanuti, and H.C. Gaissert Outcomes of patients with isolated adrenal metastasis from non-small-cell lung carcinoma Ann Thorac Surg 92 2011 1788 1792
41. A.C. Tree, V.S. Khoo, and R.A. Eeles Stereotactic body radiotherapy for oligometastases Lancet Oncol 14 2013 e28 e37
42. J.D. Luketich, N. Martini, and R.J. Ginsberg Successful treatment of solitary extracranial metastases from non-small-cell lung cancer Ann Thorac Surg 60 1995 1609 1611
43. T. Tanvetyanon, L.A. Robinson, and M.J. Schell Outcomes of adrenalectomy for isolated synchronous versus metachronous adrenal metastases in non-small-cell lung cancer: a systematic review and pooled analysis J Clin Oncol 26 2008 1142 1147
44. T. Yano, A. Haro, and T. Yoshida Prognostic impact of local treatment against postoperative oligometastases in non-small-cell lung cancer J Surg Oncol 102 2010 852 855
45. V. Getman, E. Devyatko, and D. Dunkler Prognosis of patients with non-small-cell lung cancer with isolated brain metastases undergoing combined surgical treatment Eur J Cardiothorac Surg 25 2004 1107 1113
46. Y. Saitoh, T. Fujisawa, and M. Shiba Prognostic factors in surgical treatment of solitary brain metastasis after resection of non-small-cell lung cancer Lung Cancer 24 1999 99 106
47. P. Bonnette, P. Puyo, and C. Gabriel Surgical management of non-small-cell lung cancer with synchronous brain metastases Chest 119 2001 1469 1475
48. M.T. Congedo, A. Cesario, and F. Lococo Surgery for oligometastatic non-small-cell lung cancer: long-term results from a single center experience J Thorac Cardiovasc Surg 144 2012 444 452
49. U. Abacioglu, H. Caglar, B. Atasoy, T. Abdulloev, Z. Akgun, and T. Kilic Gamma knife radiosurgery in non-small-cell lung cancer patients with brain metastases: treatment results and prognostic factors J BUON 15 2010 274 280
50. A.J. Khan, P.S. Mehta, and T.W. Zusag Long-term disease-free survival resulting from combined modality management of patients presenting with oligometastatic, non-small-cell lung carcinoma (NSCLC) Radiother Oncol 81 2006 163 167
51. K.G. Chee, D.V. Nguyen, and M. Brown Positron emission tomography and improved survival in patients with lung cancer: the Will Rogers phenomenon revisited Arch Intern Med 168 2008 1541 1549
52. A.T. Shaw, D.W. Kim, and K. Nakagawa Crizotinib versus chemotherapy in advanced ALK-positive lung cancer N Engl J Med 368 2013 2385 2394
53. M. Utley, and T. Treasure Interpreting data from surgical follow-up studies: the role of modeling J Thorac Oncol 5 2010 S200 S202
54. D.W. Andrews, C.B. Scott, and P.W. Sperduto Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial Lancet 363 2004 1665 1672
55. R.A. Patchell, P.A. Tibbs, and J.W. Walsh A randomized trial of surgery in the treatment of single metastases to the brain N Engl J Med 322 1990 494 500
56. Y.A. Lussier, H.R. Xing, and J.K. Salama MicroRNA expression characterizes oligometastasis(es) PLoS One 6 2011 e28650